Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 28;15(3):390-393.
doi: 10.17161/kjm.vol15.18431. eCollection 2022.

Pediatric COVID-19 Vaccination: A Description of Adverse Events or Reactions Reported in Kansans Aged 6 to 17

Anna Tri  1 , Kale Mills  2 , Kari Nilsen  2   3
Affiliations

Pediatric COVID-19 Vaccination: A Description of Adverse Events or Reactions Reported in Kansans Aged 6 to 17

Anna Tri et al. Kans J Med. .

Abstract

Introduction: There have been widespread concerns about the safety of the COVID-19 vaccines, particularly when it comes to pediatric populations, and it is important to provide information for parents and guardians to make informed decisions. This study sought to identify the adverse events or reactions (AERs) associated with the COVID-19 vaccines in Kansans aged 6 to 17.

Methods: The U.S. Department of Health and Human Services' "Vaccine Adverse Event Reporting System" (VAERS) database was searched from May 11, 2021, to April 30, 2022, for AERs related to COVID-19 vaccines in adolescents ages 6 to 17. Results were grouped by vaccine manufacturer and patient gender.

Results: A total of 159 individuals reported 409 AERS, with an average of 2.6 per person (± 1.7; median = 2; range 1 to 10). Females (n = 95) reported 237 AERs, with an average of 2.5 each (±1.7; median = 2; range 1 to 8), while males (n = 64) reported 172 AERs, with an average of 2.7 each (±1.8; median = 2; range 1 to 8). The most common adverse event associated with Pfizer® vaccination was syncope/fainting.

Conclusions: COVID-19 vaccines have undergone intensive monitoring and safety regulations since the onset of the coronavirus. With over 591 million doses administered, there was compelling evidence that the COVID-19 vaccines are safe and effective. Informing the public about the potential AERs of the COVID-19 vaccines in children can help to alleviate vaccine hesitancy and strengthen vaccination confidence.

Keywords: COVID-19 vaccines; Kansas; adverse drug events; vaccination; vaccine refusal.

PubMed Disclaimer

References

    1. US Centers for Disease Control and Prevention. [Accessed July 2, 2022];CDC Museum Covid-19 Timeline. 2022 January 5; www.cdc.gov/museum/timeline/covid19.html .
    1. US Food and Drug Administration. [Accessed July 2, 2022];FDA takes key action in fight against COVID-19 by issuing emergency use authorization for first COVID-19 vaccine. 2021 October 29; www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-a... .
    1. US Food and Drug Administration. [Accessed July 2, 2022];FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in children 5 through 11 years of age. 2021 October 29; www.fda.gov/news-events/press-announcements/fda-authorizes-pfizer-bionte... .
    1. Prüβ BM. Current state of the first COVID-19 vaccines. Vaccines (Basel) 2021;9(1):30. - PMC - PubMed
    1. US Centers for Disease Control and Prevention. [Accessed August 2, 2022];COVID-19 vaccines for people who are moderately or severely immunocompromised. 2022 July 20; www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html .

LinkOut - more resources